| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| NANOBIOSYM DIAGNOSTIC, INC | 1,000,000 | 1,000,000 |
| ALETHEA A/C 7700 | 1,673,073 | 5,586,947 |
| ALETHEA A/C 7699 | 1,527,291 | 1,744,436 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ALETHEA MEDTECH FUND LP | AT COST | 612,846 | 612,846 |
| ALETHEA FULCRUM FUND LP | AT COST | 2,285,903 | 2,285,903 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| MANAGEMENT FEES | 143,767 | 143,767 | 0 | |
| THROUGH ALETHEA BIOTECH FUND LP-PORTFOLIO & OTHER DEDUCTIONS | 4,454 | 4,454 | 0 | |
| THROUGH ALETHEA MEDTECH FUND LP-PORTFOLIO & OTHER DEDUCTIONS | 9,180 | 9,180 | 0 | |
| THROUGH ALETHEA MEDTECH FUND LP-ORDINARY INCOME/(LOSS) | 41,677 | 0 | 0 | |
| THROUGH ALETHEA FULCRUM FUND LP-ORDINARY INCOME/(LOSS) | 2,446 | 0 | 0 | |
| THROUGH ALETHEA FULCRUM FUND LP-PORTFOLIO & OTHER DEDUCTIONS | 57,083 | 57,083 | 0 | |
| THROUGH BROOKFIELD PROPERTY PARTNERS LP-PORTFOLIO & OTHER DEDUCTIONS | 603 | 603 | 0 | |
| PROFESSIONAL FEES | 107,255 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 10,735 | 10,735 | 0 |